Table 4.
Variable | Odds Ratio | 95% Confidence Interval |
---|---|---|
CKD stage | ||
V | 8.50 | 4.51 to 16.00b |
IV | 4.83 | 3.37 to 6.92b |
III | 1.89 | 1.39 to 2.56b |
II | 1.00 | — |
Weight z-score | 0.88 | 0.82 to 0.93c |
Primary diagnosis | ||
dysplasia | 0.93 | 0.66 to 1.30 |
reflux nephropathy | 1.09 | 0.73 to 1.62 |
FSGS | 1.00 | 0.62 to 1.59 |
other | 2.05 | 1.56 to 2.70b |
obstructive uropathy | 1.00 | — |
Iron supplementation | ||
yes | 2.39 | 1.85 to 3.08b |
no | 1.00 | — |
Erythropoietin use | ||
yes | 0.70 | 0.50 to 0.97d |
no | 1.00 | — |
Serum calcium | ||
high | 0.50 | 0.38 to 0.66b |
low | 1.31 | 0.85 to 2.03 |
normal | 1.00 | — |
Serum phosphorus | ||
high | 1.82 | 1.41 to 2.35b |
normal | 1.00 | — |
Parathyroid hormone level | ||
>2× upper limit of normal | 2.14 | 1.61 to 2.83b |
unknown | 1.29 | 1.02 to 1.63d |
<2× upper limit of normal | 1.00 | — |
Age (yr) | ||
2 to 5 | 1.84 | 1.34 to 2.54c |
6 to 12 | 1.81 | 1.40 to 2.34b |
>12 | 1.00 | — |
Antihypertensive medication use | ||
yes | 1.27 | 1.02 to 1.59d |
no | 1.00 | — |
Cohort year | ||
1994 to 1997 | 1.43 | 1.14 to 1.79c |
1998 to 2004 | 1.00 | — |
Albumin | 0.48 | 0.40 to 0.57b |
Factors included in the multivariate analysis include: age, race, gender, primary diagnosis, cohort year, height z-score, weight z-score, parathyroid hormone, calcium, phosphorus, CKD stage, albumin, antihypertensive medication use, iron supplementation, growth hormone use, and erythropoietin use.
P value < 0.0001;
P value < 0.005;
P value < 0.05.